GLA
This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
Full Name
Galactosidase Alpha
Function
Catalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome.
Biological Process
Glycoside catabolic process Source: GO_Central
Glycosphingolipid catabolic process Source: UniProtKB
Glycosylceramide catabolic process Source: UniProtKB
Negative regulation of nitric oxide biosynthetic process Source: UniProtKB
Negative regulation of nitric-oxide synthase activity Source: UniProtKB
Oligosaccharide metabolic process Source: UniProtKB
Glycosphingolipid catabolic process Source: UniProtKB
Glycosylceramide catabolic process Source: UniProtKB
Negative regulation of nitric oxide biosynthetic process Source: UniProtKB
Negative regulation of nitric-oxide synthase activity Source: UniProtKB
Oligosaccharide metabolic process Source: UniProtKB
Cellular Location
Lysosome
Involvement in disease
Fabry disease (FD):
Rare X-linked sphingolipidosis disease where glycolipid accumulates in many tissues. The disease consists of an inborn error of glycosphingolipid catabolism. FD patients show systemic accumulation of globotriaosylceramide (Gb3) and related glycosphingolipids in the plasma and cellular lysosomes throughout the body. Clinical recognition in males results from characteristic skin lesions (angiokeratomas) over the lower trunk. Patients may show ocular deposits, febrile episodes, and burning pain in the extremities. Death results from renal failure, cardiac or cerebral complications of hypertension or other vascular disease. Heterozygous females may exhibit the disorder in an attenuated form, they are more likely to show corneal opacities.
Rare X-linked sphingolipidosis disease where glycolipid accumulates in many tissues. The disease consists of an inborn error of glycosphingolipid catabolism. FD patients show systemic accumulation of globotriaosylceramide (Gb3) and related glycosphingolipids in the plasma and cellular lysosomes throughout the body. Clinical recognition in males results from characteristic skin lesions (angiokeratomas) over the lower trunk. Patients may show ocular deposits, febrile episodes, and burning pain in the extremities. Death results from renal failure, cardiac or cerebral complications of hypertension or other vascular disease. Heterozygous females may exhibit the disorder in an attenuated form, they are more likely to show corneal opacities.
View more
Anti-GLA antibodies
+ Filters
Loading...
Target: GLA
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: C6
Application*: ICC, IHC, IP, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 3B
Application*: IH
Target: GLA
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CF184
Application*: ELISA, WB, IHC, IF
Target: GLA
Host: Rabbit
Antibody Isotype: IgG
Specificity: Mouse, Rat, Human
Clone: CBLG1-2776
Application*: WB
Target: GLA
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-2776
Application*: E, IP
Target: GLA
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBLG1-1251
Application*: E
Target: GLA
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBLG1-1247
Application*: E
Target: GLA
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 1
Application*: WB
Target: GLA
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 30H11
Application*: E, IH, F
Target: GLA
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 407
Application*: ELISA, IF, IHC, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: C2
Application*: ICC, IHC, IP, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBFYH-2974
Application*: E, IF, IH, WB, IR
Target: GLA
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 201
Application*: WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-1256
Application*: E, P, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-1253
Application*: E, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-1251
Application*: E
Target: GLA
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: CBLG1-1250
Application*: WB, IP, IF, E, P
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-1247
Application*: WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 10
Application*: IF
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 13j37
Application*: E, IC, IH, WB
Target: GLA
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: 1
Application*: E, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-120
Application*: E, IC, WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBLG1-119
Application*: WB
Target: GLA
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBFYH-0371
Application*: E
More Infomation
Hot products 
-
Mouse Anti-APP Recombinant Antibody (5C2A1) (CBMAB-A3314-YC)
-
Mouse Anti-AKR1C3 Recombinant Antibody (V2-12560) (CBMAB-1050-CN)
-
Mouse Anti-CSPG4 Recombinant Antibody (CBFYM-1050) (CBMAB-M1203-FY)
-
Mouse Anti-C4B Recombinant Antibody (CBYY-C2996) (CBMAB-C4439-YY)
-
Mouse Anti-BSN Recombinant Antibody (219E1) (CBMAB-1228-CN)
-
Mouse Anti-CA9 Recombinant Antibody (CBXC-2079) (CBMAB-C0131-CQ)
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-0790) (CBMAB-0793-YY)
-
Mouse Anti-ADAM29 Recombinant Antibody (V2-179787) (CBMAB-A1149-YC)
-
Mouse Anti-AKR1B1 Antibody (V2-2449) (CBMAB-1001CQ)
-
Mouse Anti-ALPL Antibody (B4-78) (CBMAB-1009CQ)
-
Mouse Anti-BrdU Recombinant Antibody (IIB5) (CBMAB-1038CQ)
-
Rabbit Anti-BRCA2 Recombinant Antibody (D9S6V) (CBMAB-CP0017-LY)
-
Mouse Anti-AQP2 Recombinant Antibody (E-2) (CBMAB-A3358-YC)
-
Mouse Anti-BCL6 Recombinant Antibody (CBYY-0442) (CBMAB-0445-YY)
-
Mouse Anti-CRYAB Recombinant Antibody (A4345) (CBMAB-A4345-YC)
-
Rabbit Anti-ALK (Phosphorylated Y1278) Recombinant Antibody (D59G10) (PTM-CBMAB-0035YC)
-
Rabbit Anti-AKT2 (Phosphorylated S474) Recombinant Antibody (V2-556130) (PTM-CBMAB-0605LY)
-
Mouse Anti-AMACR Recombinant Antibody (CB34A) (CBMAB-CA034LY)
-
Mouse Anti-BZLF1 Recombinant Antibody (BZ.1) (CBMAB-AP705LY)
-
Mouse Anti-FLI1 Recombinant Antibody (CBXF-0733) (CBMAB-F0435-CQ)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry




